Resources

Arena Pharmaceuticals, Inc., said last Friday its obesity drug candidate Lorcaserin met primary efficacy and safety endpoints in the second late-stage trial, dubbed BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management).

A solid majority of physicians favor creating a new public insurance option that would operate alongside existing private plans, according to a survey published online in The New England Journal of Medicine.

Women with diabetes are less likely to get important cancer screening tests than women without diabetes, new research confirms.

A new study shows that foreign-born adults with diabetes who move to the US are less apt to get certain types of recommended care than native-born US citizens with diabetes.

Metabolic syndrome (MetS) in women is associated with an increased risk for future symptomatic peripheral artery disease (PAD), according to the results of a prospective cohort study.

No matter how old you are, increased physical activity is associated with decreased mortality and improved function, a longitudinal Israeli study found.

A new study in animals demonstrates that a diet rich in coconut oil protects against ‘insulin resistance’ (an impaired ability of cells to respond to insulin) in muscle and fat. The diet also avoids the accumulation of body fat caused by other high fat diets of similar calorie content.

In a bid to ramp up the public health battle against obesity, a group of nutrition and economics experts are pushing for a tax of 1 cent on every of ounce of sodas and other sweetened beverages.

Generex Biotechnology Corporation, an innovator for drug delivery for metabolic diseases through the inner lining of the mouth, announced that the U.S. FDA has granted approval for the treatment use of Oral-lyn™ under the FDA’s Treatment Investigational New Drug (IND) program.

In patients with recent onset Type 2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve glucose control, according to a study.